Amyt stock alert: halper sadeh llc is investigating whether the sale of amryt pharma plc is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of amryt pharma plc (nasdaq: amyt) to chiesi farmaceutici s.p.a. is fair to amryt shareholders. per the terms of the proposed transaction, chiesi would acquire amryt for $14.50 in cash per american depositary share (ads) of amryt plus contingent value rights of up to $2.50 per ads payable if certain milestones related to amryt's product filsuvez® are achieved.
AMYT Ratings Summary
AMYT Quant Ranking